Donepezil HCL

Treatment of mild to moderate Alzheimer's syndrome. It✔ is the second drug approved by FDA for Alzheimer's disease in the  United States. Its treatment reaches the target dose and has low toxic and si$de effects. It has been widely recognized by our medical αcommunity, and good tolerance is its biggest advantage. In October 1999, Do§nepezil was launched in China under the trade name "Aricept", which is the main che♦mical drug against Alzheimer's disease. At present, CFDA has approved a number §of domestic enterprises to produce donepezil preparations, the main dosage forms are ta♣blets, capsules, dispersive tablets, oral disintegrating tablets.

key word:

domestic preparations

Category:

Related

Product Description

Integrity, innovation, cooperation, sharing, win-win

The company integrates multiple resources and strives t♠o build a large health industry finance platform company integ∑rating pharmaceutical, intelligent medical, bio pharmaceutical R&D, in☆dustrial production and sales.

The chemical reactions involved in the existing products‌ include Foucault reaction, nitration reaction, sulfonation reaction, hydrogenatio✘n reaction, fluorination reaction, chlorination reaction, bromination reaction, diazotizat ion reaction, format reaction, etc.

Treatment of mild to moderate Alzheimer's syndrome. It is the second drug approved by FDA f✘or Alzheimer's disease in the United States. Its treatment reaches" the target dose and has low toxic and side effects. It has been widely recognized by♥ our medical community, and good tolerance is its biggest advantage. In October 1999, Done★pezil was launched in China under the trade name "Aricept", ♠which is the main chemical drug against Alzheimer's disease. At pr esent, CFDA has approved a number of domestic enterprises to produce donepezil preparations, the♥ main dosage forms are tablets, capsules, dispersive tablets, oral disintegratinσg tablets.

Related products

Sitagliptin Phosphate Monohydrate

Sitagliptin phosphate is a dipeptidyl peptidase-4 (DPP4) inhibitor developed by Merc k. In October 2006, Sitagliptin phosphate Januvia was approv±ed by FDA as the first DPP4 inhibitor for the treatment of type ⅱ diabetes mellitus. The charact↑eristics of this drug are that it can stimulate insulin secretion while reducing hunger without c•ausing weight gain. Hypoglycemia and edema will not occur, and it is suitable φfor diabetic patients with poor blood glucose control "and frequent hypoglycemia.

Sumatriptan Succinate

Medication for migraine

Vildagliptin

Chenglian Pharmaceutical is an innovative high-tech pharmaceut♣ical enterprise that is market-oriented and realizes industrial development throug©h R&D innovation and technology transformation.

Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen is one o≥f the most important products for the treatment of arthritis. It •is well tolerated and has a low incidence of side effects

Pranlukast

Pranlukast, developed by Ono, is one of the three major leukotriene receptor antagonists. In≈ clinical application, it has good therapeutic effect on atopic asthma and≠ other types of bronchial asthma, and the market prospect is hu•ge. In the major category of asthma drugs, leukotriene receptor antagonist₽s have the fastest growing market share.

Avanafil

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterp±rise that is market-oriented and realizes industrial development through R&D innovationλ and technology transformation.

Donepezil HCL

Treatment of mild to moderate Alzheimer's syndrome. It is the sec✔ond drug approved by FDA for Alzheimer's disease in the United Stat₩es. Its treatment reaches the target dose and has low t≠oxic and side effects. It has been widely recognized by our medical Ωcommunity, and good tolerance is its biggest advantage. In October 1999, Don≥epezil was launched in China under the trade name "Aricept", which is the main chemical drug agains→t Alzheimer's disease. At present, CFDA has approved a number of domestic enterprises to produce do↔nepezil preparations, the main dosage forms are tablets,ε capsules, dispersive tablets, oral disintegrating tablets.

Almotriptan

Migraine medication for adolescents

Apixaban

English name Apixaban Trade name ELIQUIS, tablet: Apixaban (Eliquis→, Bristol-Myers Squibb/Pfizer), a direct oral factor Xa inhibitor, was approved for use i✔n the 27 EU member states. The world's first drug approved to prev₽ent venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacπement. From June 2019 to June 2020, the annual sales of apixaban products o verseas reached about $15.4 billion, with a year-on-year growth ofΩ nearly 32%, and the API consumption reached about 23,960 kg, with a year-on-year growth of§ about 28%. Compared with its main competitor, Rivaroxaban, ±the drug's annual overseas sales are about $4.5 billion higher.

Lenvatinib

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is market-¥oriented and realizes industrial development through R&D↑ innovation and technology transformation.

Clofarabine

It is a nucleotide analogue developed by Bioenvision and ma✔nufactured by Genzyme. On December 29, 2004, it was approved by FDA for< the treatment of refractory or relapsed acute lymphoblastic leukeαmia (ALL) in children.

Upadacitinib(Scientific research)

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enter•prise that is market-oriented and realizes industrial development through R&D innovatαion and technology transformation.

Product Consulting

Our staff will contact you within 24 hours (working d↕ays). If you need other services, E-mail: 2880705932@qq.com

Copyright © 2022 Anhui Union Pharmaceuticals Technology Co.↔, Ltd.